Joan H. Dunlop
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Joan H. Dunlop has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Corinne A. Keet
Division of Pediatric Allergy and Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland
1 shared publicationJoshua P. Keller
Department of Statistics, Colorado State University, Fort Collins, Colorado
1 shared publicationMia MacDonald
1 shared publicationRachel Kyte
1 shared publicationRobert A. Wood
Division of Pediatric Allergy and Immunology, Johns Hopkins University School of Medicine, Baltimore, Md
1 shared publicationRoger D. Peng
Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
1 shared publication
Latest Publications
- 1 May 2021
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 9 (5) , 1890-1891
Peanut Oral Immunotherapy: Is the Second Year the Charm?
- 1 May 2021
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 9 (5) , 1890-1891
Peanut Oral Immunotherapy: Is the Second Year the Charm?
- 1 August 2020
- Published by SAGE Publications in Journal of Investigative Medicine
- Vol. 68 (6) , 1152-1155
Oral Immunotherapy for Treatment of Peanut Allergy
The US Food and Drug Administration's approval of a peanut oral immunotherapy product in January 2020 is a landmark development in the field of food allergy therapy. While food allergy prevalence has been increasing, this product is the first approved therapy for food allergy. Oral immunotherapy has many similarities to subcutaneous immunotherapy and drug desensitization protocols, but does not lead to sustained unresponsiveness. The studies leading to approval of the Palforzia product demonstrated increase in the amount of peanut protein able to be consumed, with 67% of subjects randomized to the treatment arm able to consume 600 mg of peanut protein in double-blind placebo-controlled food challenge at study exit. However, side effects are an important consideration, and dropout rates in studies of Palforzia ranged from 11% to 21%. Postmarketing surveillance of this product will be critical in assessing its long-term risks and benefits.
- 1 August 2020
- Published by SAGE Publications in Journal of Investigative Medicine
- Vol. 68 (6) , 1152-1155
Oral Immunotherapy for Treatment of Peanut Allergy
The US Food and Drug Administration's approval of a peanut oral immunotherapy product in January 2020 is a landmark development in the field of food allergy therapy. While food allergy prevalence has been increasing, this product is the first approved therapy for food allergy. Oral immunotherapy has many similarities to subcutaneous immunotherapy and drug desensitization protocols, but does not lead to sustained unresponsiveness. The studies leading to approval of the Palforzia product demonstrated increase in the amount of peanut protein able to be consumed, with 67% of subjects randomized to the treatment arm able to consume 600 mg of peanut protein in double-blind placebo-controlled food challenge at study exit. However, side effects are an important consideration, and dropout rates in studies of Palforzia ranged from 11% to 21%. Postmarketing surveillance of this product will be critical in assessing its long-term risks and benefits.
- 1 August 2020
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 125 (2) , 221-223.e2
The effect of season of birth on atopic dermatitis and food allergy
- 1 August 2020
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 125 (2) , 221-223.e2
The effect of season of birth on atopic dermatitis and food allergy
- 1 March 1996
- Published by Project MUSE in SAIS Review of International Affairs
- Vol. 16 (1) , 153-165
Women Redrawing the Map: The World After the Beijing and Cairo Conferences
- 1 March 1996
- Published by Project MUSE in SAIS Review of International Affairs
- Vol. 16 (1) , 153-165
Women Redrawing the Map: The World After the Beijing and Cairo Conferences